TruWealth Advisors LLC Has $254,000 Stock Holdings in The Allstate Co. (NYSE:ALL)

TruWealth Advisors LLC lowered its holdings in shares of The Allstate Co. (NYSE:ALLFree Report) by 13.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,320 shares of the insurance provider’s stock after selling 205 shares during the period. TruWealth Advisors LLC’s holdings in Allstate were worth $254,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Meiji Yasuda Asset Management Co Ltd. grew its holdings in Allstate by 8.9% in the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 4,137 shares of the insurance provider’s stock worth $661,000 after purchasing an additional 337 shares during the period. XTX Topco Ltd grew its stake in shares of Allstate by 82.0% in the 2nd quarter. XTX Topco Ltd now owns 6,608 shares of the insurance provider’s stock valued at $1,055,000 after buying an additional 2,978 shares during the period. Brighton Jones LLC increased its position in Allstate by 7.5% in the 2nd quarter. Brighton Jones LLC now owns 4,132 shares of the insurance provider’s stock valued at $660,000 after buying an additional 287 shares in the last quarter. Benjamin F. Edwards & Company Inc. raised its stake in Allstate by 25.1% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 24,949 shares of the insurance provider’s stock worth $3,984,000 after buying an additional 4,998 shares during the period. Finally, Canada Pension Plan Investment Board boosted its holdings in Allstate by 41.5% in the second quarter. Canada Pension Plan Investment Board now owns 384,217 shares of the insurance provider’s stock worth $61,344,000 after acquiring an additional 112,753 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors.

Allstate Price Performance

Shares of NYSE:ALL opened at $188.85 on Friday. The company has a market capitalization of $50.01 billion, a P/E ratio of 12.23, a price-to-earnings-growth ratio of 1.35 and a beta of 0.52. The company’s 50-day moving average is $195.73 and its 200 day moving average is $186.32. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The Allstate Co. has a fifty-two week low of $150.17 and a fifty-two week high of $209.88.

Allstate (NYSE:ALLGet Free Report) last released its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The firm had revenue of $16.63 billion for the quarter, compared to analysts’ expectations of $14.57 billion. During the same period in the previous year, the company earned $0.81 earnings per share. The company’s quarterly revenue was up 14.7% on a year-over-year basis. On average, equities research analysts forecast that The Allstate Co. will post 16.45 earnings per share for the current year.

Allstate Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th were given a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 1.95%. The ex-dividend date was Friday, November 29th. Allstate’s dividend payout ratio is currently 23.83%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on ALL. Raymond James boosted their price objective on Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a report on Friday, October 4th. Keefe, Bruyette & Woods upped their price objective on shares of Allstate from $235.00 to $243.00 and gave the stock an “outperform” rating in a report on Friday, January 10th. Piper Sandler lifted their price objective on shares of Allstate from $206.00 to $244.00 and gave the company an “overweight” rating in a report on Tuesday, November 26th. Barclays lowered their target price on shares of Allstate from $187.00 to $183.00 and set an “underweight” rating on the stock in a report on Monday, January 6th. Finally, Jefferies Financial Group lifted their price target on Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a research note on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Allstate currently has an average rating of “Moderate Buy” and a consensus target price of $218.13.

Check Out Our Latest Research Report on ALL

Allstate Company Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Further Reading

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALLFree Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.